QuantLogix ← LLY scorecard
📅 LLY Earnings Preview
Eli Lilly & Co.
Next report (est.)
April 28, 2026
Countdown
Imminent
EPS growth YoY
+51.4%
Revenue growth YoY
+42.6%
Options-implied earnings move
±3.3%
The at-the-money straddle prices a move to roughly $1170.20 or $1095.80 from $1133.00 by June 18, 2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
October 30, 2025 ±2.3% +3.8% under-priced
August 7, 2025 ±3.1% -14.1% under-priced
May 1, 2025 ±2.8% -11.7% under-priced
October 30, 2024 ±1.4% -6.3% under-priced
August 8, 2024 ±5.2% +9.5% under-priced
April 30, 2024 ±2.2% +6.0% under-priced
November 2, 2023 ±2.8% +4.7% under-priced
August 8, 2023 ±1.5% +14.9% under-priced
Across these reports, options implied an average ±2.6% move vs an actual average of 8.9% — the stock stayed inside the implied band 0% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q4 FY2025 $7.39 $19.3B $6.6B
Q3 FY2025 $6.21 $17.6B $5.6B
Q2 FY2025 $6.29 $15.6B $5.7B
Q1 FY2025 $3.06 $12.7B $2.8B
Analyst posture
Buy / Strong Buy
31
Hold
7
Sell
1
Stable: +1 net change 30d
Live 5-factor engine read: Buy · 63/100 Full scorecard →
Get alerted before every LLY report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on LLY before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Eli Lilly & Co. (LLY) reports imminently, with the next report estimated for April 28, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 8.9% on average — the market has tended to under-price LLY's earnings risk. Fundamentals into the print: EPS up 51.4% year-over-year, revenue up 42.6%. QuantLogix's live 5-factor engine currently reads LLY as a buy at 63/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →